G1 Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
G1 Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • G1 Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.35M, a 20.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.35M -$1.1M -20.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.63M -$1.08M -18.9% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $4.91M -$1.05M -17.7% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $5.18M -$1.06M -17% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $5.45M -$1.06M -16.3% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $5.71M -$1.07M -15.8% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $5.96M -$1.07M -15.3% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $6.24M -$1.05M -14.4% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $6.51M -$1.03M -13.7% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $6.78M -$1.01M -13% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $7.04M -$991K -12.3% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $7.29M -$972K -11.8% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $7.54M -$955K -11.2% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $7.79M -$1.33M -14.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $8.03M -$1.83M -18.5% Dec 31, 2020 10-K 2022-02-23
Q3 2020 $8.26M -$1.89M -18.6% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $8.5M +$7.13M +524% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $9.12M +$7.67M +530% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $9.85M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $10.2M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $1.36M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.45M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.